Abstract
The objective of this study was to report three cases with an accumulation of 131I in the nasolacrimal duct after radioiodine therapy for papillary thyroid cancer. A whole-body scan was taken 3 days after the administration of 3.7 GBq of 131I. Single-photon emission computed tomography (SPECT)/CT images were added when the location of a focal tracer uptake was undetermined on whole-body scans. In case 1, a 62-year-old woman complained of epiphora of the left eye after nine radioiodine therapies with a cumulative dose of 31.08 GBq. The left nasolacrimal duct was visualized at her tenth treatment with 131I. In case 2, a series of three radioiodine therapies had been given to a 73-year-old woman with a cumulative dose of 11.1 GBq. The accumulation of 131I was noted in the left nasolacrimal duct at her fourth treatment. She complained of epiphora of the left eye. In case 3, bilateral nasolacrimal ducts were visualized at the second radioiodine therapy in a 75-year-old woman. The patient had received 3.7 GBq of 131I at the first therapy. She did not complain of epiphora. It is possible that radiation from 131I that is secreted in tears and/or actively accumulated in the nasolacrimal duct may induce nasolacrimal duct obstruction. 131I in tears would be responsible for the visualization of nasolacrimal duct in the first two cases. 131I actively accumulated in the nasolacrimal duct might have been visualized in the third case. In summary, 131I is excreted in tears and is actively accumulated in the nasolacrimal duct. Obstruction of the lacrimal drainage system could occur after high-dose radioiodine therapy.
Similar content being viewed by others
References
G Zettinig G Hanselmayer BJ Fueger A Hofmann C Pirich J Nepp et al. (2002) ArticleTitleLong-term impairment of the lacrimal glands after radioiodine therapy: a cross-sectional study Eur J Nucl Med Mol Imaging 29 1428–32 Occurrence Handle12397459 Occurrence Handle10.1007/s00259-002-0969-0 Occurrence Handle1:CAS:528:DC%2BD38XotV2isbw%3D
RT Kloos V Duvuuri SM Jhiang KV Cahill JA Foster JA Burns (2002) ArticleTitleNasolacrimal drainage system obstruction from radioactive iodine therapy for thyroid carcinoma J Clin Endocrinol Metab 87 5817–20 Occurrence Handle12466391 Occurrence Handle10.1210/jc.2002-020210 Occurrence Handle1:CAS:528:DC%2BD38XpslWmsrc%3D
TR Shepler SI Sherman MM Faustina NL Busaidy MA Ahmadi B Esmaeli (2003) ArticleTitleNasolacrimal duct obstruction associated with radioactive iodine therapy for thyroid carcinoma Ophthal Plast Reconstr Surg 19 479–81 Occurrence Handle14625496 Occurrence Handle10.1097/01.IOP.0000092802.75899.F8
JA Burns KE Morgenstern KV Cahill JA Foster SM Jhiang RT Kloos (2004) ArticleTitleNasolacrimal obstruction secondary to 131I therapy Ophthal Plast Reconstr Surg 20 126–9 Occurrence Handle15083081 Occurrence Handle10.1097/01.IOP.0000117340.41849.81 Occurrence Handle1:STN:280:DC%2BD2c7oslyhug%3D%3D
H Brockmann K Wilhelm A Joe H Palmedo HJ Biersack (2005) ArticleTitleNasolacrimal drainage obstruction after radioiodine therapy: case report and a review of the literature Clin Nucl Med 30 543–5 Occurrence Handle16024949 Occurrence Handle10.1097/01.rlu.0000170013.84378.2a
SM Bakheet MM Hammami A Hemidan JE Powe F Bajaafar (1998) ArticleTitleRadioiodine secretion in tears J Nucl Med 39 1452–4 Occurrence Handle9708527 Occurrence Handle1:CAS:528:DyaK1cXls1aisbg%3D
KE Morgenstern DD Vadysirisack Z Zhang KV Cahill JA Foster JA Burns et al. (2005) ArticleTitleExpression of sodium iodide symporter in the lacrimal drainage system: implication for the mechanism underlying nasolacrimal duct obstruction in 131I-treated patients Ophthal Plast Reconstr Surg 21 337–44 Occurrence Handle16234694 Occurrence Handle10.1097/01.iop.0000179369.75569.a8
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sakahara, H., Yamashita, S., Suzuki, K. et al. Visualization of nasolacrimal drainage system after radioiodine therapy in patients with thyroid cancer. Ann Nucl Med 21, 525–527 (2007). https://doi.org/10.1007/s12149-007-0056-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12149-007-0056-5